NCT03809533View on ClinicalTrials.gov

The Use of Hepatitis C Positive Kidneys in Hepatitis C Negative Kidney Transplant Recipients

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 29, 2019

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2026

Conditions
Kidney TransplantationHepatitis C
Interventions
DRUG

sofosbuvir/velpatasvir

12-week, oral, fixed-dose

Trial Locations (1)

15213

UPMC, Pittsburgh

All Listed Sponsors
collaborator

University of Pittsburgh Medical Center

OTHER

lead

Amit D Tevar, MD

OTHER